15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering MacroGenics Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $2.00 to $9.00 (about 4.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $5.50 sits 43% above the current $3.83. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.31 next quarter toward $-1.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to MacroGenics Inc.
As of Jul, 3 of 4 firms rate MGNX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MGNX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.31
Range $-0.68 – $-0.05 · 4 analysts · -216% YoY
Next period, 4 analysts expect MacroGenics Inc to earn $-0.31 a share (range $-0.68 – $-0.05), versus $0.27 a year earlier. Full-year consensus is $0.04, growing to $-1.41 the year after.
REVENUE · NEXT QUARTER
$32.9M
Range $1.5M – $65.1M · 4 analysts · -55% YoY
Revenue is expected to reach $32.9M (range $1.5M – $65.1M), -54.9% year-over-year. Full-year consensus is $164.4M, rising to $94.3M next year.
Top analysts covering MacroGenics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MGNX.
#1
Mayank Mamtani
B. Riley Securities · Rank #9
Buy
$9.00+134.7% to target
Overall win rate
53%
+ Follow
#2
Silvan Tuerkcan
JMP Securities · Rank #29
Hold
No targeton MGNX
Overall win rate
50%
+ Follow
#3
Yigal Nochomovitz
Citigroup · Rank #131
Buy
$14.00+265.1% to target
Overall win rate
43%
+ Follow
#4
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Hold
$2.00-47.8% to target
Overall win rate
38%
+ Follow
#5
Etzer Darout
Barclays
Buy
$6.00+56.5% to target
Coverage
—
+ Follow
MGNX stock forecast FAQ
What is MGNX's average 12-month price target?+
The 3 analysts with a live target average $5.50 for MacroGenics Inc over the next 12 months, ranging from a $9.00 high to a $2.00 low.
Is MGNX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MGNX?+
The Street-high target is $9.00 (B. Riley Securities), and the Street-low is $2.00 (HC Wainwright & Co.). The average of all 3 active targets is $5.50.
How many Wall Street analysts cover MGNX?+
4 analysts have an active rating on MacroGenics Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering MGNX?+
Among analysts who currently cover MGNX, Mayank Mamtani of B. Riley Securities has the strongest overall Quantellect track record (Rank #9). Their current call is Buy with a $9.00 target.
What is MacroGenics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.31 per share (range $-0.68 – $-0.05) across 4 analysts. Full-year EPS is projected at $0.04, rising to $-1.41 the following year.
How much revenue is MacroGenics Inc expected to report next quarter?+
Consensus revenue is $32.9M (range $1.5M – $65.1M). Full-year revenue is projected at $164.4M, growing to $94.3M next year.
Have analysts been upgrading or downgrading MGNX lately?+
As of Jul, 3 of 4 firms rate MGNX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MGNX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
